Announcing MedTech Actuator Origin Japan’s semi-finalists
After three days of working closely with 13 medical startups in Japan, the MedTech Actuator is excited to announce four semi-finalists who will join the MedTech Actuator Origin in Australia next month.
MedTech Actuator Origin Japan – an early-stage innovation program for MedTech, BioTech, and HealthTech startups looking to explore Australia and the Asia-Pacific market – kicked off its second cohort this week, welcoming a diverse range of medical and health innovations that spanned across diagnostic imaging and data management in hospital settings, bioprinting, spinal implants, Autism Spectrum Disorder (ASD) screening, and cancer treatments and care.
Emerging founders and entrepreneurs joined MedTech Actuator and partners, JETRO, OCCI, OBDA and industry experts, for a 2-day bootcamp in Osaka. Together, they learned about pitching their innovations to a global market, commercialisation strategies and more. The program culminated at a semi-final, where each startup pitched for their chance to come to Australia and join MedTech Actuator Origin in November.
Congratulations to AI4ASD, FairMed, Smile Curve and Spine Chronicle Japan Co. Ltd
Judges and industry guests were blown away by the medical innovations and quality of each pitch. Congratulations to the selected semi-finalists:
- AI4ASD | Aki Kono | An AI early screening tool for Autism Spectrum Disorder.
- FairMed | Sumire Fukuda | The development of AI to Assist Endovascular Surgery.
- Smile Curve | Masakatsu Noguchi | A new screening system with ICT to quantitatively measure body surface distortion without X-ray exposure, enabling scoliosis screening.
- Spine Chronicle Japan | Ryo Kitagawa | Development of the best spinal implants for elderly patients.
These Japanese startups will join MedTech Actuator in Melbourne next month for a week-long intensive program, where they will learn from industry experts, pressure test their innovations, and network with and pitch to Australia’s startup ecosystem.
One Japanese startup will ultimately be selected to pitch at the MedTech Actuator Showcase – an industry event attended by 300 experts in BioMedical innovation on November 30. At this event, startups will compete for a chance to win a cash and in-kind prize pack worth over $20,000, a one-on-one session with Synchron founder and inaugural MedTech Actuator Origin alumni, Associate Professor Thomas Oxley, and a fast-tracked entry into MedTech Actuator Accelerator 2024 to accelerate the commercialisation of their ideas.
MedTech Actuator Origin Japan is sponsored by JETRO and co-organized with JETRO, OCCI and OBDA.
Stay in the loop by signing up for news and updates below.